Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer

Copyright © 2016. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 176(2017) vom: 01. März, Seite 63-70
Auteur principal: Zirakzadeh, A Ali (Auteur)
Autres auteurs: Kinn, Johan, Krantz, David, Rosenblatt, Robert, Winerdal, Malin E, Hu, Jin, Hartana, Ciputra Adijaya, Lundgren, Christian, Bergman, Emma Ahlén, Johansson, Markus, Holmström, Benny, Hansson, Johan, Sidikii, Alexander, Vasko, Janos, Marits, Per, Sherif, Amir, Winqvist, Ola
Format: Article en ligne
Langue:English
Publié: 2017
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't B cells CD86 Doxorubicin Immunology Neoadjuvant chemotherapy Urinary bladder cancer B7-2 Antigen Tumor Necrosis Factor-alpha plus... Interleukin-10 130068-27-8 80168379AG